menu
    • menu

    Company profile for 4D Molecular Therapeutics

    NEW Drugs in Dev: 7
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    4DMT is a gene therapy company with a transformative discovery platform—Therapeutic Vector Evolution—that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    4D Molecular TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5858 Horton St. Suite 455 Emeryville, CA 94608
    Telephone
    Telephone
    (510) 505-2680
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://4dmoleculartherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    4DMT To Participate In Upcoming Investor Conferences
    4DMT To Participate In Upcoming Investor Conferences

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241011/0/en/4DMT-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    4DMT Announces New Employment Inducement Grants
    4DMT Announces New Employment Inducement Grants

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238322/0/en/4DMT-Announces-New-Employment-Inducement-Grants.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    4DMT Completes Enrollment For 4FRONT-1 Phase 3 Clinical Trial
    4DMT Completes Enrollment For 4FRONT-1 Phase 3 Clinical Trial

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234480/0/en/4DMT-Completes-Enrollment-for-4FRONT-1-Phase-3-Clinical-Trial-of-4D-150-in-Wet-AMD.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    4DMT Announces New Employment Inducement Grants
    4DMT Announces New Employment Inducement Grants

    17 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/17/3220622/0/en/4DMT-Announces-New-Employment-Inducement-Grants.html

    GLOBENEWSWIRE
    17 Jan 2026
    Share Share
    4DMT Shares 2026 Development Milestone Updates
    4DMT Shares 2026 Development Milestone Updates

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214461/0/en/4DMT-Provides-Company-Update-and-Anticipated-Development-Milestones-for-2026.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    4DMT Announces Positive Interim Clinical Data From 4D-710 AEROW
    4DMT Announces Positive Interim Clinical Data From 4D-710 AEROW

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206872/0/en/4DMT-Announces-Positive-Interim-Clinical-Data-from-4D-710-AEROW-Phase-1-Clinical-Trial-in-Cystic-Fibrosis-Lung-Disease.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search